⌕
MBX Biosciences · MBX · Nasdaq
Tenet 53 · Mixed
Compare
$53.10−0.04%At closeTenet 53 · Mixed
$53.10−0.02 (−0.04%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

MBX Biosciences (MBX) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● GlobeNewsWireNov 9, 2026 · 16:01 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 9
MBX Biosciences Reports Third Quarter 2026 Financial Results and Corporate Highlights

Enrollment in pivotal Phase 3 oPTimize trial of once-weekly canvuparatide underway 12-week MAD (Part C, Cohort 1) data for MBX 4291, a GLP-1/GIP co-agonist prodrug for obesity designed for once-monthly dosing, on track f…

● AccesswireOct 19, 2026 · 07:00 ETEARNINGS EXPECTED BY FEB 9
Microbix Attending & Presenting at IPVS 2026

Presenting Results of Novel Product for Validation & QC of HPV Assays MISSISSAUGA, ON / ACCESS Newswire / October 19, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix®), a life sciences innovator, manufact…

● GlobeNewsWireOct 13, 2026 · 08:00 ETCOMPANY'S OWN WORDS
MBX Biosciences to Participate in Upcoming November Investor Conferences

CARMEL, Ind. and BURLINGTON, Mass.…

● Defense WorldSep 30, 2026 · 06:21 ET
MBX Biosciences (NASDAQ:MBX) Shares Climb 4.1% – Time to Buy?

Shares of MBX Biosciences, Inc. (NASDAQ: MBX - Get Free Report) rose 4.1% during trading on Monday. The stock traded as high as $55.93 and last traded at $55.84. 88,613 shares were traded during mid-day trading, a declin…

● Defense WorldSep 25, 2026 · 03:23 ETEARNINGS EXPECTED BY FEB 9
MBX Biosciences, Inc. $MBX Shares Newly Bought by Bank of America Corp DE

Bank of America Corp DE bought a new position in MBX Biosciences, Inc. (NASDAQ: MBX) during a recent quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 298,927 s…

● Seeking AlphaSep 23, 2026 · 15:51 ET
MBX Biosciences: I Should Never Have Downgraded To Hold (Rating Upgrade)

MBX Biosciences, Inc. is upgraded to Buy, driven by strong canvuparatide Phase 2 data and a clear path to Phase 3 success in hypoparathyroidism. Canvuparatide's once-weekly dosing and robust efficacy position MBX to chal…

● Seeking AlphaSep 16, 2026 · 15:21 ET
MBX Biosciences, Inc. (MBX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

MBX Biosciences, Inc. (MBX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript…

● GlobeNewsWireSep 9, 2026 · 08:00 ETCOMPANY'S OWN WORDS
MBX Biosciences to Participate in Upcoming Investor Conferences

CARMEL, Ind., and BURLINGTON, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel…

● GlobeNewsWireSep 8, 2026 · 08:00 ETCOMPANY'S OWN WORDS
MBX Biosciences Announces Appointment of Jeff Held as Chief Legal Officer

CARMEL, Ind. and BURLINGTON, Mass.…

● Defense WorldSep 8, 2026 · 04:51 ETEARNINGS EXPECTED BY FEB 9
Jupiter Topco LLC Acquires Shares of 10,300 MBX Biosciences, Inc. $MBX

Jupiter Topco LLC acquired a new position in shares of MBX Biosciences, Inc. (NASDAQ: MBX) during a recent quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The …

● GlobeNewsWireAug 27, 2026 · 08:00 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 9
MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism

Pivotal Phase 3 oPTimize trial design builds on positive Phase 2 Avail™ results and durable one-year clinical benefit…

Kept in their own lane. A press release is the company talking, not reporting.

Expected by Feb 9. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

Quiet tape today.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.